Skip Navigation

Annals of Oncology 2009 20(3):401-402; doi:10.1093/annonc/mdp039
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ruddy, K. J.
Right arrow Articles by Partridge, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruddy, K. J.
Right arrow Articles by Partridge, A. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

editorials

Adherence with adjuvant hormonal therapy for breast cancer

K. J. Ruddy and A. H. Partridge*

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

* (E-mail: Ann_Partridge@dfci.harvard.edu)

The first 10% of the full text of this article appears below.

Nonadherence to oral medication is an increasingly recognized concern in the care of patients with cancer [1]. In women with hormone-sensitive breast cancer, long-term daily oral hormonal therapy has been shown repeatedly in clinical trials to significantly reduce risk of recurrence and improve survival. Every year, hundreds of thousands of women worldwide are recommended to take tamoxifen (TAM) or an aromatase inhibitor for ≥5 years. Patient adherence (taking doses as prescribed) and persistence (not discontinuing the medication entirely) with these agents is essential to the ability of these treatments to improve outcomes.

In this issue, Ziller et al. retrospectively . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?